MRI "Target Sign" and Neurofibromatosis Type 1
Neurol 78:e63, Ghosh,P.S. and Ghosh,D., 2012
Hydrocephalus in Patients with Neurofibromatosis Type 1: MR Imaging Findings and the Outcome of Endoscopic Third Ventriculostomy
AJNR 32:643-46, Dincer, A.,et al, 2011
Neurofibromatosis Type 2
Lancet 373:1974-1986, Astagiri,A.R.,et al, 2009
Diagnostic Approach in Patients with Symmetric Imaging Lesions of the Deep Gray Nuclei
The Neurologist 9:250-261, Finelli,P.F.&DiMario,Jr,F.J., 2003
Hyperintense Basal Ganglia on T1-Weighted MR Imaging
AJR 172:1109-1115, Lai,P.H.,et al, 1999
Magnetic Resonance Imaging Lesion Analysis in Neurofibromatosis Type 1
Arch Neurol 55:500-505, DiMario,F.J.&Ramsby,G., 1998
Cognitive Function and Academic Performance in Neurofibromatosis 1:North
K. N. , et al, Neurol 48:1121-11277., , 1997
Evolution of High-Intensity Basal Ganglia Lesions on T1-Weighted MR in Neurofibramotisis Type 1
AJNR 17:755-760, Terada,H.A.,et al, 1996
Neurofibromatosis Type 1:Pathologic Substrate of High-Signal-Intensity Foci in the Brain
Radiology 195:721-724, DiPaolo,D.P.,et al, 1995
Brainstem Tumors in Patients with Neurofibromatosis Type 1:A Distinct Clinical Entity
Neurol 45:1897-1902, Molloy,P.T.,et al, 1995
Neurofibroma Manifested by Spinal Subarachnoid Hemorrhage
AJR 162:959-960, Cummings,T.M.&Johnson,M.H., 1994
Cerebrovascular Abnormalities in Neurofibromatosis Type 1
Neurol 44:1000-1002, Rizzo,J.F.&Lessell,S., 1994
Neurofibromatosis Type 1:The Cognitive Phenotype
J Pediatr 124:S1-S8, Hofman,K.J.,et al, 1994
Specific Learning Disability in Children with Neurofibromatosis Type 1:Significance of MRI Abnormalities
Neurol 44:878-883, North,K.,et al, 1994
Natural History of Optic Pathway Tumors in Children with Neurofibromatosis Type I:A Longitudinal Study
J Pediatr 125:63-66, Listernick,R.,et al, 1994
Skin Lesions of the Spinal Axis and Spinal Dysraphism:Fifteen Cases & Review of the Literature
Arch Pediatr Adolesc Med 148:740-748, McAtee-Smith,J.,et al, 1994
Intradural Conus and Cauda Equina Tumours:A Retrospective Review of Presentation, Diagnosis & Early Outcome
JNNP 56:69-74, Mathew,P.&Todd,N.V., 1993
Evolution of White Matter Lesions in Neurofibromatosis Type 1:MR Findings
AJR 159:171-175, Sevick,R.J.,et al, 1992
Midbrain Myasthenia:Fatigable Ptosis, 'Lid Twitch'Sign, and Ophthalmoparesis From a Dorsal Midbrain Glioma
Neurol 42 917-919, Ragge,N.K.&Hoyt,W.F., 1992
Emergence of Optic Pathway Gliomas in Children with Neurofibromatosis-1 After Normal Neuroimaging
J Pediatr 121:584-587, Listernick,R.,et al, 1992
High-Intensity Basal Ganglia Lesions on T1-Weighted MR Images in Neurofibromatosis
AJR 154:369-373, Mirowitz,S.A.,et al, 1990
Neurofibromatosis 2 (Bilateral Acoustic Neurofibromatosis) An Update
Ann Int Med 113:39-52, Mulvihill,J.J.,et al, 1990
The Significance of MRI Abnormalities in Children with Neurofibromatosis
Neurol 39:373-378, Duffner,P.K.,et al, 1989
Neurofibromatosis Types 1 and 2:Cranial MR Findings
Radiology 172:527-534, Aoki,S.,et al, 1989
A New Sign of Neurofibromatosis on Magnetic Resonance Imaging of Children
Arch Neurol 46:1222-1224, Goldstein,S.M.,et al, 1989
Neurofibromatosis 2 (Bilateral Acoustic Neuro-fibromatosis)
NEJM 318:684-688, Martuza,R.L.&Eldridge,R., 1988
Symptomatic Hydrocephalus:Initial Findings in Brainstem Gliomas not Detected on Computed Tomographic Scans
Pediatrics 82:733-737, Raffel,C.,et al, 1988
Bornavirus Encephalitis Shows a Characteristic Magnetic Resonance Phenotype in Humans
Ann Neurol 88:723-735, Finck, T.,et al, 2020
Paraneoplastic and Autoimmune Encephalitis
UptoDate July, Dalmau, J.,et al, 2017
Superior MRI Outcomes with Alemtuzumab Compared with Subcutaneous Interferon �-1a in MS
Neurol 87:1464-1472, Arnold, D.L.,et al, 2016
Spectrum of Imaging Appearances of Intracranial Cryptococcal Infection in HIV/AIDS Patients in the Anti-Retroviral Therapy Era
Clin Radiol 71:9-17, Offiah, C.E. & Naseer, A., 2016
Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 373:1418-1428, Kappos, L.,et al, 2015
Target Sign on Enhanced MR Imaging in Toxoplasmosis
Conn Med 77:343-344, Finelli, P.F. & Al Zahmi, F., 2013
Morvan Syndrome: Clinical and Serological Observations in 29 Cases
Ann Neurol 72:241-255, Irani, S.R.,et al, 2012
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
NEJM 367:1087-1097,1149, Fox, R.J.,et al, 2012
Central Nervous System Lymphoma: Characteristic Findings on Traditional and Advanced Imaging
AJNR 32:984-992, Haldorsen, I.S.,et al, 2011
Fulminant Encephalopathy with Basal Ganglia Hyperintensities in HIV-infected Drug Users
Neurol 77:923, Finelli, P.F., 2011
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
NEJM 362:402-415, 456, Cohen,J.A.,et al, 2010
JC Virus Infection of the Brain
AJNR 31:1564-1576, Bag,A.K.,et al, 2010
Imaging Manifestations of Progressive Multifocal Leukoencephalopathy
Clinical Radiol 65:431-439, Shah,R.,et al, 2010
Eccentric Target Sign in Cerebral Toxoplasmosis - Neuropathological Correlate to the Imaging Feature
J Magn Reson Imaging 31:1469-1472, Kumar, G.S.,et al, 2010
Efficacy of Treatment of MS with IFN B-1b or Glatiramer Acetate by Monthly Brain MRI in the BECOME Study
Neurol 72:1976-1983,1972, Cadavid,D.,et al, 2009
Frequent Hemorrhagic Lesions in Cerebral Toxoplasmosis in AIDS Patients
J Neuroimaging 19:169-173, Bhagavati, S. & Choe, J., 2009
A Parkinsonian Syndrome in Methcathinone Users and the Role of Manganese
NEJM 358:1009-1017, Stepens,A.,et al, 2008
Randomized, Double-Blind, Dose-Comparison Study of Glatiramer Acetate in Relapsing-Remitting MS
Neurol 68:939-944, Cohen,J.A.,et a, 2007
Neutralizing Antibodies to Interferon Beta: Assessment of Their Clinical and Radiographic Impact: An Evidence Report
Neurol 68:977-984, Goodin,D.S.,et al, 2007
Multiple Ring Enhancing Lesions in Brain MRI of a Patient with AIDS
JNNP 78:526, Tahir,M.,et al, 2007
Inflammatory Progressive Multifocal Leukoencephalopathy in Human Immunodeficiency Virus-Negative Patients
Ann Neurol 62:34-39, Huang,D.R.,et al, 2007
Mangnetic Resonance Imaging Effects of Interferon Beta-1b in the BENEFIT Study: Integrated 2-Year Results
Arch Neurol 64:1292-1298, Barkhof,F.,et al, 2007